Enabling every cure for community matters: Our AI-powered journey
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.
The Future of Aging, AI, and Robotics with CEO of Insilico Medicine – Alex Zhavoronkov, PhD | VibeCast Episode 52
In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey starting the company in 2014. Insilico Medicine’s mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Aging research and drug development in the era of AI […]
Mother-Son Duo Offer Biopharma KOL Mapping with Adnexi CEO – Sandra Shpilberg | VibeCast Episode 50
In this episode, VibeCast host Ray Dogum speaks with Sandra Shpilberg, Co-founder and CEO of Adnexi, about using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch. The Importance of Collaboration in Drug Development In the pharmaceutical industry, collaboration plays a crucial role in driving […]
The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio
Watch the 3 part podcast episode on YouTube! We are proud to share a recent The Biotech Startups Podcast episode hosted by Jon Chee, CEO of Excedr. In the episode, Jon and Alok discuss the many opportunities that can improve the biotech industry and how Vibe Bio is tackling the problem of funding & guiding […]
